GENEVA, SWITZERLAND – For the past several years Alcon has behaved like a utility company. Financial results increase at a ...

Needham analyst David Saxon reiterated a Buy rating on Alcon (ALC – Research Report) today and set a price target of $107.00. David Saxon has given his Buy rating due to a combination of factors such ...

EST Alcon (ALC) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

Alcon expects 2024 sales of $9.8 billion to $9.9 billion, compared with prior guidance of $9.9 billion to $10.1 billion. It expects core earnings per share of $3 to $3.05, compared with a previous ...

Tarsus Pharmaceuticals (NASDAQ:TARS) has pared some of an earlier gain of as much as 13% and is now up 8%  amid a report that ...

For the quarter ended September 2024, Alcon (ALC) reported revenue of $2.43 billion, up 5.6% over the same period last year. EPS came in at $0.81, compared to $0.66 in the year-ago quarter. The ...

53 LR Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and nine month periods ending September 30, 2024. For the third quarter of 2024, sales were $2.4 ...

The groundbreaking innovation of the ACTIV-FLO System in PRECISION7 is a unique combination of a water-loving moisturizing ...

Alcon (NYSE:ALC) is scheduled to announce Q3 earnings results on Wednesday, November 13th, before market open. The consensus EPS Estimate is $0.74 (+12.1% Y/Y) and the consensus Revenue Estimate is $2 ...

Lifecore now operates at less than 35% utilization, meaning that it can almost triple revenue with virtually no additional ...

We recently compiled a list of the UBS’ Top Tech Based Disruptive Stocks For 2030: Top 29 Stocks. In this article, we are ...

Alcon had asked court to force NSSF to compensate it for its equipment and machinery that the Fund has been holding since ...